Related Experiment Video

Updated: Jun 27, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

The influence of hyperlipidemia on platelet activity markers in patients after ischemic stroke

Malgorzata Pawelczyk1, Zbigniew Baj, Henryk Chmielewski

  • 1Departments of Neurology and Epileptology, Medical University of Lodz, Zeromskiego Str. 113, Lodz, Poland. gosiagalka@poczta.onet.pl

Cerebrovascular Diseases (Basel, Switzerland)
|December 3, 2008
PubMed

Insights

Hyperlipidemia in stroke patients increases platelet activation, indicated by higher CD62P expression and platelet-derived microparticles. This suggests hyperlipidemia is a risk factor for vascular events post-stroke.

Area of Science:

  • Cardiovascular Science
  • Hematology
  • Neurology

Background:

  • Ischemic stroke patients exhibit altered platelet activity.
  • Hyperlipidemia is a common comorbidity in stroke survivors.
  • Platelet activation markers like P-selectin and microparticles are implicated in vascular events.

Purpose of the Study:

  • To examine the association between hyperlipidemia and platelet activation markers in post-ischemic stroke patients.
  • To compare platelet activation levels in hyperlipidemic versus normolipidemic stroke patients.

Main Methods:

  • Flow cytometry was used to analyze CD62P-positive platelets and platelet-derived microparticles (PDMPs) in 41 ischemic stroke patients and 20 healthy controls.
  • Platelet activation was assessed using thrombin stimulation.
  • Serum soluble P-selectin (sP-selectin) levels were measured via ELISA.

Main Results:

  • Hyperlipidemic (HL) stroke patients showed significantly higher CD62P expression on resting and activated platelets compared to normolipidemic (NL) patients.
  • Serum sP-selectin concentrations were significantly elevated in the HL group versus the NL group.
  • Both NL and HL stroke patients had a significantly higher percentage of PDMPs compared to controls, with HL patients showing a trend towards higher levels.

Conclusions:

  • Stroke patients demonstrate platelet hyperreactivity.
  • Hyperlipidemia appears to be a significant risk factor for vascular events in stroke patients due to enhanced platelet activation.
  • Targeting platelet activation in hyperlipidemic stroke survivors may reduce vascular event risk.
Abstract

Related Concept Videos

Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...